Clinical Trial Update: A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 real-world study of pyrrolitinib maleate tablets in patients with HER2-positive breast cancer that is early-sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrrolitinib Maleate Tablets (pyrrolitinib maleate)

Snippet

Sponsor: Zunyi Medical College | Conditions: HER-2 Positive Advanced Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING